WOLVERINE TRADING, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 102 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$3,387
-89.7%
25,700
-61.6%
0.00%
Q2 2023$32,933
+80224.4%
67,004
+7.7%
0.00%
Q1 2023$41
-51.2%
62,196
-52.0%
0.00%
Q4 2022$84
-100.0%
129,460
-41.1%
0.00%
Q3 2022$435,000
+178.8%
219,835
+74.9%
0.00%
Q2 2022$156,000
+345.7%
125,659
+141.6%
0.00%
Q1 2022$35,000
-67.9%
52,018
-46.4%
0.00%
Q4 2021$109,000
-53.8%
97,000
+10.5%
0.00%
Q2 2021$236,000
-54.1%
87,819
-42.4%
0.00%
-100.0%
Q1 2021$514,000
+83.6%
152,350
+44.0%
0.00%
Q4 2020$280,000
+33.3%
105,777
+29.5%
0.00%
Q3 2020$210,000
-57.1%
81,700
-46.3%
0.00%
-100.0%
Q2 2020$489,000
-16.4%
152,173
-33.7%
0.00%
-50.0%
Q1 2020$585,000
-54.8%
229,486
-15.1%
0.00%
-33.3%
Q4 2019$1,295,000
+3.3%
270,208
-9.1%
0.00%
-25.0%
Q3 2019$1,254,000
-31.6%
297,146
-5.5%
0.00%
-33.3%
Q2 2019$1,834,000
+48.6%
314,584
-1.9%
0.01%
+50.0%
Q1 2019$1,234,000
+79.1%
320,757
-22.7%
0.00%
+100.0%
Q4 2018$689,000
-12.5%
414,879
+106.7%
0.00%0.0%
Q2 2018$787,0000.0%200,7230.0%0.00%0.0%
Q1 2018$787,000
-6.8%
200,723
-1.5%
0.00%
-33.3%
Q4 2017$844,000
+0.5%
203,811
+49.0%
0.00%0.0%
Q3 2017$840,000
-54.4%
136,817
-52.2%
0.00%
-70.0%
Q1 2017$1,844,000
+1.0%
285,986
-16.2%
0.01%
+11.1%
Q4 2016$1,826,000
-6.0%
341,300
-2.0%
0.01%0.0%
Q3 2016$1,943,000
-30.5%
348,123
-28.2%
0.01%
-40.0%
Q2 2016$2,797,000484,8410.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders